Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Front Pediatr ; 12: 1423858, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39005503

RESUMO

Common variable immunodeficiency is a heterogeneous symptomatic group of inborn errors of immunity that mainly affects antibodies production and/or function, predisposing patients to recurrent and severe infections. More than half of them usually develop autoimmunity, lymphoproliferation, enteropathy, and malignancies. Among these conditions, chronic lung disease such as granulomatous-lymphocytic interstitial lung disease is one of the leading causes of death in these patients. Recently, many genes that play a key role in B and T cells' development, maintenance, and/or cytokines signaling pathways have been implicated in the pathogenesis of the disease. Here, we describe the first Argentinian patient presenting with common variable immunodeficiency and granulomatous-lymphocytic interstitial lung disease, harboring two in cis heterozygous variants in the SOCS1 gene.

2.
Arch. argent. pediatr ; 121(1): e202202885, feb. 2023. tab
Artigo em Espanhol | LILACS, BINACIS | ID: biblio-1413466

RESUMO

Los errores innatos de la inmunidad (EII), antes llamados inmunodeficiencias primarias (IDP), son un grupo heterogéneo de trastornos genéticos con defectos en uno o más componentes del sistema inmune. Los pacientes afectados por EII presentan aumentada susceptibilidad a microorganismos únicos o múltiples que se manifestará con infecciones recurrentes de diferente tipo y gravedad dependiendo del tipo de la localización del defecto. La prevención de infecciones es uno de los pilares fundamentales en el abordaje integral de los pacientes con EII. En este trabajo se resumen las conclusiones consensuadas en el Grupo de Trabajo de Inmunología Pediátrica de la Sociedad Argentina de Pediatría, sobre la base de la revisión de la evidencia disponible, respecto a los principios esenciales para el cuidado, la prevención de infecciones y la quimioprofilaxis en los errores innatos de la inmunidad para la orientación del pediatra y especialista dedicados al seguimiento de estas enfermedades.


Inborn errors of immunity, previously named primary immunodeficiency are a heterogeneous group of genetic defects of different components of the immune system. Patients present high susceptibility to an only or several microorganisms, developing recurrent infections; the severity is related to the specific genetic type of immunity defect. The main strategy on the management of these illness is the prevention of infections. These consensus guidelines made by the Pediatric Immunology Work Group of Sociedad Argentina de Pediatría, givese main approaches of infection prevention in order to provide a useful tool for all practitioners who are involved in the management of these patients, based on scientific evidence and broad consensus of a specialized panel expert.


Assuntos
Humanos , Criança , Quimioprevenção , Doenças do Sistema Imunitário/congênito
3.
Arch Argent Pediatr ; 121(1): e202202885, 2023 02 01.
Artigo em Espanhol | MEDLINE | ID: mdl-36701243

RESUMO

Inborn errors of immunity, previously named primary immunodeficiency are a heterogeneous group of genetic defects of different components of the immune system. Patients present high susceptibility to an only or several microorganisms, developing recurrent infections; the severity is related to the specific genetic type of immunity defect. The main strategy on the management of these illness is the prevention of infections. These consensus guidelines made by the Pediatric Immunology Work Group of Sociedad Argentina de Pediatría, givese main approaches of infection prevention in order to provide a useful tool for all practitioners who are involved in the management of these patients, based on scientific evidence and broad consensus of a specialized panel expert..


Los errores innatos de la inmunidad (EII), antes llamados inmunodeficiencias primarias (IDP), son un grupo heterogéneo de trastornos genéticos con defectos en uno o más componentes del sistema inmune. Los pacientes afectados por EII presentan aumentada susceptibilidad a microorganismos únicos o múltiples que se manifestará con infecciones recurrentes de diferente tipo y gravedad dependiendo del tipo de la localización del defecto. La prevención de infecciones es uno de los pilares fundamentales en el abordaje integral de los pacientes con EII. En este trabajo se resumen las conclusiones consensuadas en el Grupo de Trabajo de Inmunología Pediátrica de la Sociedad Argentina de Pediatría, sobre la base de la revisión de la evidencia disponible, respecto a los principios esenciales para el cuidado, la prevención de infecciones y la quimioprofilaxis en los errores innatos de la inmunidad para la orientación del pediatra y especialista dedicados al seguimiento de estas enfermedades.


Assuntos
Quimioprevenção , Criança , Humanos , Argentina
4.
J Allergy Clin Immunol Pract ; 7(5): 1568-1577, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30716504

RESUMO

BACKGROUND: In the warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome, variable phenotypic expression may delay diagnosis. Panleukopenia, malignancy, and chronic lung disease all affect morbidity and mortality risks. Routinely used treatments include immunoglobulins, granulocyte-colony stimulating factor (G-CSF), and antibiotics; recent trials with a target C-X-C chemokine receptor type 4 (CXCR4) antagonist show promising results. OBJECTIVE: We sought to characterize the largest cohort of patients with WHIM and evaluate their diagnostic and therapeutic management. METHODS: Data were collected from an international cohort of 18 patients with CXCR4 mutations. RESULTS: The clinical features manifested at 2.2 ± 2.6 years of age, whereas the disease diagnosis was delayed until 12.5 ± 10.4 years of age. Patients with WHIM commonly presented with a severe bacterial infection (78%). Pneumonia recurrence was observed in 61% of patients and was complicated with bronchiectasis in 27%. Skin warts were observed in 61% of patients at a mean age of 11 years, whereas human papilloma virus (HPV)-related malignancies manifested in 16% of patients. All the patients had severe neutropenia (195 ± 102 cells/mm3 at onset), whereas lymphopenia and hypogammaglobulinemia were detected in 88% and 58% of patients, respectively. Approximately 50% of patients received antibiotic prophylaxis, whereas G-CSF and immunoglobulin treatments were used in 72% and 55% of patients, respectively. CONCLUSIONS: The WHIM syndrome onsets early in life and should be suspected in patients with chronic neutropenia. Patients with WHIM need careful monitoring and timely intervention for complications, mainly lung disease and HPV-related malignancies. We suggest that immunoglobulin therapy should be promptly considered to control the frequency of bacterial infections and prevent chronic lung damage.


Assuntos
Bronquiectasia/fisiopatologia , Infecções por Papillomavirus/fisiopatologia , Pneumonia/fisiopatologia , Doenças da Imunodeficiência Primária/fisiopatologia , Verrugas/fisiopatologia , Anormalidades Múltiplas , Adolescente , Adulto , Idade de Início , Antibacterianos/uso terapêutico , Antineoplásicos/uso terapêutico , Neoplasias do Ânus/etiologia , Neoplasias do Ânus/terapia , Neoplasias do Ânus/virologia , Criança , Pré-Escolar , Doença Crônica , Códon sem Sentido , Estudos de Coortes , Criocirurgia , Diagnóstico Tardio , Progressão da Doença , Feminino , Mutação da Fase de Leitura , Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Cardiopatias Congênitas , Humanos , Imiquimode/uso terapêutico , Lactente , Recém-Nascido , Ceratolíticos/uso terapêutico , Deformidades Congênitas dos Membros , Pneumopatias/fisiopatologia , Linfopenia/fisiopatologia , Masculino , Pessoa de Meia-Idade , Infecções por Papillomavirus/complicações , Doenças da Imunodeficiência Primária/genética , Doenças da Imunodeficiência Primária/imunologia , Doenças da Imunodeficiência Primária/terapia , Receptores CXCR4/genética , Retinoides/uso terapêutico , Ácido Salicílico/uso terapêutico , Neoplasias do Colo do Útero/etiologia , Neoplasias do Colo do Útero/terapia , Neoplasias do Colo do Útero/virologia , Verrugas/genética , Verrugas/imunologia , Verrugas/terapia , Adulto Jovem
5.
Arch. argent. pediatr ; 115(6): 458-461, dic. 2017. ilus
Artigo em Espanhol | LILACS, BINACIS | ID: biblio-887414

RESUMO

Antecedentes: Arthrographis kalrae es un hongo hialino de crecimiento lento que, en su desarrollo, forma artroconidios. Es un patógeno oportunista que causa infecciones en personas inmunocomprometidas e inmunocompetentes, y ha sido aislado muy raramente en muestras clínicas de seres humanos. Caso clínico: Se describe el caso de un paciente con inmunodeficiencia primaria y afectación pulmonar con evolución tórpida. Presentó compromiso de ambos pulmones a pesar del tratamiento antibiótico y antifúngico instaurado. Durante su seguimiento, se realizaron múltiples biopsias pulmonares y se aisló A. kalrae en el cultivo de tejido pulmonar. Recibió tratamiento con posaconazol, con buena respuesta y remisión de las lesiones. Conclusión: Este es el primer caso reportado de infección pulmonar por A. kalrae en un paciente pediátrico con enfermedad granulomatosa crónica en Argentina.


Background: Arthrographis kalrae is a hyaline fungus that grows forming arthroconidia. It is an opportunistic pathogen that causes infections in immunocompromised as in immunocompetent people and has been rarely isolated from human clinical samples. Case report: We describe the case of a male child with primary immunodeficiency who initially presented unilateral pneumonia and progressed to bilateral involvement despite antibiotic, antifungal treatment. A. kalrae was diagnosed by pulmonary biopsy. He received posaconazole with resolution of disease. Conclusions: This is the first case of A. kalrae pulmonary infection in a pediatric patient with chronic granulomatous disease in Argentina.


Assuntos
Humanos , Masculino , Pré-Escolar , Ascomicetos , Doença Granulomatosa Crônica/complicações , Pneumopatias Fúngicas/microbiologia , Micoses/complicações , Pneumopatias Fúngicas/tratamento farmacológico , Micoses/microbiologia , Micoses/tratamento farmacológico
6.
Arch Argent Pediatr ; 115(6): e458-e461, 2017 Dec 01.
Artigo em Espanhol | MEDLINE | ID: mdl-29087135

RESUMO

BACKGROUND: Arthrographis kalrae is a hyaline fungus that grows forming arthroconidia. It is an opportunistic pathogen that causes infections in immunocompromised as in immunocompetent people and has been rarely isolated from human clinical samples. CASE REPORT: We describe the case of a male child with primary immunodeficiency who initially presented unilateral pneumonia and progressed to bilateral involvement despite antibiotic, antifungal treatment. A. kalrae was diagnosed by pulmonary biopsy. He received posaconazole with resolution of disease. CONCLUSIONS: This is the first case of A. kalrae pulmonary infection in a pediatric patient with chronic granulomatous disease in Argentina.


ANTECENDENTES: Arthrographis kalrae es un hongo hialino de crecimiento lento que, en su desarrollo, forma artroconidios. Es un patógeno oportunista que causa infecciones en personas inmunocomprometidas e inmunocompetentes, y ha sido aislado muy raramente en muestras clínicas de seres humanos. CASO CLÍNICO: Se describe el caso de un paciente con inmunodeficiencia primaria y afectación pulmonar con evolución tórpida. Presentó compromiso de ambos pulmones a pesar del tratamiento antibiótico y antifúngico instaurado. Durante su seguimiento, se realizaron múltiples biopsias pulmonares y se aisló A. kalrae en el cultivo de tejido pulmonar. Recibió tratamiento con posaconazol, con buena respuesta y remisión de las lesiones. CONCLUSIÓN: Este es el primer caso reportado de infección pulmonar por A. kalrae en un paciente pediátrico con enfermedad granulomatosa crónica en Argentina.


Assuntos
Ascomicetos , Doença Granulomatosa Crônica/complicações , Pneumopatias Fúngicas/microbiologia , Micoses/complicações , Pré-Escolar , Humanos , Pneumopatias Fúngicas/tratamento farmacológico , Masculino , Micoses/tratamento farmacológico , Micoses/microbiologia
7.
J Allergy Clin Immunol ; 133(4): 1134-41, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24679470

RESUMO

BACKGROUND: Severe combined immunodeficiency (SCID) is a syndrome characterized by profound T-cell deficiency. BCG vaccine is contraindicated in patients with SCID. Because most countries encourage BCG vaccination at birth, a high percentage of patients with SCID are vaccinated before their immune defect is detected. OBJECTIVES: We sought to describe the complications and risks associated with BCG vaccination in patients with SCID. METHODS: An extensive standardized questionnaire evaluating complications, therapeutics, and outcomes regarding BCG vaccination in patients given a diagnosis of SCID was widely distributed. Summary statistics and association analysis was performed. RESULTS: Data on 349 BCG-vaccinated patients with SCID from 28 centers in 17 countries were analyzed. Fifty-one percent of the patients had BCG-associated complications, 34% disseminated and 17% localized (a 33,000- and 400-fold increase, respectively, over the general population). Patients receiving early vaccination (≤1 month) showed an increased prevalence of complications (P = .006) and death caused by BCG-associated complications (P < .0001). The odds of experiencing complications among patients with T-cell numbers of 250/µL or less at diagnosis was 2.1 times higher (95% CI, 1.4-3.4 times higher; P = .001) than among those with T-cell numbers of greater than 250/µL. BCG-associated complications were reported in 2 of 78 patients who received antimycobacterial therapy while asymptomatic, and no deaths caused by BCG-associated complications occurred in this group. In contrast, 46 BCG-associated deaths were reported among 160 patients treated with antimycobacterial therapy for a symptomatic BCG infection (P < .0001). CONCLUSIONS: BCG vaccine has a very high rate of complications in patients with SCID, which increase morbidity and mortality rates. Until safer and more efficient antituberculosis vaccines become available, delay in BCG vaccination should be considered to protect highly vulnerable populations from preventable complications.


Assuntos
Vacina BCG/efeitos adversos , Imunodeficiência Combinada Severa/epidemiologia , Vacina BCG/imunologia , Pré-Escolar , Comorbidade , Feminino , Transplante de Células-Tronco Hematopoéticas , Humanos , Lactente , Recém-Nascido , Estimativa de Kaplan-Meier , Masculino , Prevalência , Estudos Retrospectivos , Risco , Imunodeficiência Combinada Severa/diagnóstico , Imunodeficiência Combinada Severa/terapia , Vacinação/efeitos adversos , Vacinação/legislação & jurisprudência
8.
J Clin Immunol ; 33(7): 1216-22, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23846854

RESUMO

PURPOSE: Several studies have shown that subcutaneous immunoglobulin (SCIG) infusions demonstrate similar efficacy to intravenous Ig (IVIG) in preventing infections in patients with primary immunodeficiency diseases (PID), and are safe and well tolerated in this population. This open, prospective/retrospective, multicenter study was designed to compare the effectiveness, safety and tolerability of a 16 % liquid human IgG preparation (Beriglobina P), administered SC, with previous IVIG treatment in PID pediatric patients in Argentina. METHODS: Fifteen subjects were enrolled in the study, and a total of 13 subjects (aged 6-18 years) completed the 36-week SCIG treatment period. All children had previously received IVIG treatment. The dose of SCIG equaled the previous IVIG dose and subjects received an average weekly dose of 139 mg/kg (range 105-181) during the SCIG period. RESULTS: Significantly higher serum IgG trough levels were recorded on SCIG treatment at 16, 24, and 36 weeks, when compared with previous IgG trough levels on steady-state IVIG treatment. The annualized infection rate was 1.4 infections/subject/year during the IVIG administration period compared with 0.4 infections/subject/year during the SCIG period. All subjects who completed the study chose to continue administering SCIG at home after the study had ended. CONCLUSIONS: These data confirm that self-administered SCIG therapy is a well-tolerated and effective alternative to IVIG therapy for children with PID.


Assuntos
Imunoglobulina G/administração & dosagem , Imunoglobulinas Intravenosas/administração & dosagem , Síndromes de Imunodeficiência/terapia , Imunoterapia/métodos , Infecções/terapia , Adolescente , Argentina , Criança , Estudos de Viabilidade , Feminino , Humanos , Imunoglobulina G/sangue , Síndromes de Imunodeficiência/complicações , Síndromes de Imunodeficiência/epidemiologia , Síndromes de Imunodeficiência/imunologia , Infecções/epidemiologia , Infecções/imunologia , Injeções Subcutâneas , Masculino , Estudos Prospectivos
11.
Arch. argent. pediatr ; 104(5): 441-444, oct. 2006. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-450041

RESUMO

La disqueratosis congénita o síndrome de Zinsser Egman Cole es una forma muy poco frecuente de dermatosis que se caracteriza por hiperpigmentación reticulada cutánea, distrofia de faneras, leucoplasia premaligna de la mucosa oral y pancitopenia progresiva. El objetivo de este trabajo fue la presentación de un paciente de sexo masculino, actualmente de 8 años, que consultó por anemia ferropénica, trastornos tróficos de piel y mucosas, leucoplasia severa de lengua y disfagia para sólidos semi sólidos, a quien se hizo diagnóstico inicial de síndrome de Plummer Vinson por la presencia de membranas esofágicas altas. La persistencia de la clínica con la aparición de hiperpigmentación reticulada en cuello y tronco y leucopenia progresiva hizo sospechar esta patología que fue confirmada por el estudio genético correspondiente


Assuntos
Masculino , Humanos , Criança , Disceratose Congênita , Doenças Genéticas Ligadas ao Cromossomo X , Hiperpigmentação , Leucoplasia Oral
12.
Arch. argent. pediatr ; 104(5): 441-444, oct. 2006. ilus, tab
Artigo em Espanhol | BINACIS | ID: bin-121539

RESUMO

La disqueratosis congénita o síndrome de Zinsser Egman Cole es una forma muy poco frecuente de dermatosis que se caracteriza por hiperpigmentación reticulada cutánea, distrofia de faneras, leucoplasia premaligna de la mucosa oral y pancitopenia progresiva. El objetivo de este trabajo fue la presentación de un paciente de sexo masculino, actualmente de 8 años, que consultó por anemia ferropénica, trastornos tróficos de piel y mucosas, leucoplasia severa de lengua y disfagia para sólidos semi sólidos, a quien se hizo diagnóstico inicial de síndrome de Plummer Vinson por la presencia de membranas esofágicas altas. La persistencia de la clínica con la aparición de hiperpigmentación reticulada en cuello y tronco y leucopenia progresiva hizo sospechar esta patología que fue confirmada por el estudio genético correspondiente(AU)


Assuntos
Masculino , Humanos , Criança , Disceratose Congênita , Leucoplasia Oral , Hiperpigmentação , Doenças Genéticas Ligadas ao Cromossomo X
13.
Arch. argent. pediatr ; 104(5): 441-444, oct. 2006. ilus, tab
Artigo em Espanhol | BINACIS | ID: bin-119192

RESUMO

La disqueratosis congénita o síndrome de Zinsser Egman Cole es una forma muy poco frecuente de dermatosis que se caracteriza por hiperpigmentación reticulada cutánea, distrofia de faneras, leucoplasia premaligna de la mucosa oral y pancitopenia progresiva. El objetivo de este trabajo fue la presentación de un paciente de sexo masculino, actualmente de 8 años, que consultó por anemia ferropénica, trastornos tróficos de piel y mucosas, leucoplasia severa de lengua y disfagia para sólidos semi sólidos, a quien se hizo diagnóstico inicial de síndrome de Plummer Vinson por la presencia de membranas esofágicas altas. La persistencia de la clínica con la aparición de hiperpigmentación reticulada en cuello y tronco y leucopenia progresiva hizo sospechar esta patología que fue confirmada por el estudio genético correspondiente(AU)


Assuntos
Masculino , Humanos , Criança , Disceratose Congênita , Leucoplasia Oral , Hiperpigmentação , Doenças Genéticas Ligadas ao Cromossomo X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...